MATER TODAY BIO 润色咨询

Materials Today Bio

出版年份：暂无数据 年文章数：252 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2264002, encodeId=df7022640023f, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf439560030, createdName=ms8000001925736583, createdTime=Thu May 08 10:49:21 CST 2025, time=2025-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2260232, encodeId=d8c12260232fc, content=投稿命中率:25.0<br>偏重的研究方向：生物学<br>经验分享：投稿了一次，送审很快，审稿完成，等待编辑决定呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e14c55942, createdName=lanhai, createdTime=Sun Apr 13 18:08:40 CST 2025, time=2025-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2219820, encodeId=3e6222198204f, content=暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e529420835, createdName=ms2000000634155448, createdTime=Tue Aug 13 08:56:19 CST 2024, time=2024-08-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2156580, encodeId=df8621565804a, content=审稿速度:2.0<br>经验分享：之前投过一次，编辑综合审稿人意见让修改后重投，7月17日投稿，很快送外审，9月4号外审结束（Required Reviews Completed），不知这次编辑怎么看？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ff0b2457930, createdName=StarJay, createdTime=Thu Sep 07 16:41:33 CST 2023, time=2023-09-07, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1243071, encodeId=af3412430e142, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：医学;纳米<br>经验分享：杂志非常效率，1个月内给结果。找了5个审稿人，审稿人意见专业中肯。今年IF10.78，值得投资。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c322575811, createdName=12592582m91暂无昵称, createdTime=Sun Sep 04 09:52:39 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116663, encodeId=7c5d1116663f0, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221462, encodeId=e0a512214620d, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:00 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116664, encodeId=833a11166643f, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2025-05-08 ms8000001925736583 来自山东省

    审稿速度:2.0 | 投稿命中率:75.0
    经验分享：很快

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2264002, encodeId=df7022640023f, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf439560030, createdName=ms8000001925736583, createdTime=Thu May 08 10:49:21 CST 2025, time=2025-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2260232, encodeId=d8c12260232fc, content=投稿命中率:25.0<br>偏重的研究方向：生物学<br>经验分享：投稿了一次，送审很快，审稿完成，等待编辑决定呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e14c55942, createdName=lanhai, createdTime=Sun Apr 13 18:08:40 CST 2025, time=2025-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2219820, encodeId=3e6222198204f, content=暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e529420835, createdName=ms2000000634155448, createdTime=Tue Aug 13 08:56:19 CST 2024, time=2024-08-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2156580, encodeId=df8621565804a, content=审稿速度:2.0<br>经验分享：之前投过一次，编辑综合审稿人意见让修改后重投，7月17日投稿，很快送外审，9月4号外审结束（Required Reviews Completed），不知这次编辑怎么看？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ff0b2457930, createdName=StarJay, createdTime=Thu Sep 07 16:41:33 CST 2023, time=2023-09-07, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1243071, encodeId=af3412430e142, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：医学;纳米<br>经验分享：杂志非常效率，1个月内给结果。找了5个审稿人，审稿人意见专业中肯。今年IF10.78，值得投资。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c322575811, createdName=12592582m91暂无昵称, createdTime=Sun Sep 04 09:52:39 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116663, encodeId=7c5d1116663f0, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221462, encodeId=e0a512214620d, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:00 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116664, encodeId=833a11166643f, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2025-04-13 lanhai 来自吉林省

    投稿命中率:25.0
    偏重的研究方向：生物学
    经验分享：投稿了一次，送审很快，审稿完成，等待编辑决定呢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2264002, encodeId=df7022640023f, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf439560030, createdName=ms8000001925736583, createdTime=Thu May 08 10:49:21 CST 2025, time=2025-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2260232, encodeId=d8c12260232fc, content=投稿命中率:25.0<br>偏重的研究方向：生物学<br>经验分享：投稿了一次，送审很快，审稿完成，等待编辑决定呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e14c55942, createdName=lanhai, createdTime=Sun Apr 13 18:08:40 CST 2025, time=2025-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2219820, encodeId=3e6222198204f, content=暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e529420835, createdName=ms2000000634155448, createdTime=Tue Aug 13 08:56:19 CST 2024, time=2024-08-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2156580, encodeId=df8621565804a, content=审稿速度:2.0<br>经验分享：之前投过一次，编辑综合审稿人意见让修改后重投，7月17日投稿，很快送外审，9月4号外审结束（Required Reviews Completed），不知这次编辑怎么看？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ff0b2457930, createdName=StarJay, createdTime=Thu Sep 07 16:41:33 CST 2023, time=2023-09-07, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1243071, encodeId=af3412430e142, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：医学;纳米<br>经验分享：杂志非常效率，1个月内给结果。找了5个审稿人，审稿人意见专业中肯。今年IF10.78，值得投资。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c322575811, createdName=12592582m91暂无昵称, createdTime=Sun Sep 04 09:52:39 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116663, encodeId=7c5d1116663f0, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221462, encodeId=e0a512214620d, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:00 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116664, encodeId=833a11166643f, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2024-08-13 ms2000000634155448 来自黑龙江省

    暂无

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2264002, encodeId=df7022640023f, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf439560030, createdName=ms8000001925736583, createdTime=Thu May 08 10:49:21 CST 2025, time=2025-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2260232, encodeId=d8c12260232fc, content=投稿命中率:25.0<br>偏重的研究方向：生物学<br>经验分享：投稿了一次，送审很快，审稿完成，等待编辑决定呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e14c55942, createdName=lanhai, createdTime=Sun Apr 13 18:08:40 CST 2025, time=2025-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2219820, encodeId=3e6222198204f, content=暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e529420835, createdName=ms2000000634155448, createdTime=Tue Aug 13 08:56:19 CST 2024, time=2024-08-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2156580, encodeId=df8621565804a, content=审稿速度:2.0<br>经验分享：之前投过一次，编辑综合审稿人意见让修改后重投，7月17日投稿，很快送外审，9月4号外审结束（Required Reviews Completed），不知这次编辑怎么看？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ff0b2457930, createdName=StarJay, createdTime=Thu Sep 07 16:41:33 CST 2023, time=2023-09-07, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1243071, encodeId=af3412430e142, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：医学;纳米<br>经验分享：杂志非常效率，1个月内给结果。找了5个审稿人，审稿人意见专业中肯。今年IF10.78，值得投资。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c322575811, createdName=12592582m91暂无昵称, createdTime=Sun Sep 04 09:52:39 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116663, encodeId=7c5d1116663f0, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221462, encodeId=e0a512214620d, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:00 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116664, encodeId=833a11166643f, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2023-09-07 StarJay 来自陕西省

    审稿速度:2.0
    经验分享：之前投过一次，编辑综合审稿人意见让修改后重投，7月17日投稿，很快送外审，9月4号外审结束（Required Reviews Completed），不知这次编辑怎么看？

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2264002, encodeId=df7022640023f, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf439560030, createdName=ms8000001925736583, createdTime=Thu May 08 10:49:21 CST 2025, time=2025-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2260232, encodeId=d8c12260232fc, content=投稿命中率:25.0<br>偏重的研究方向：生物学<br>经验分享：投稿了一次，送审很快，审稿完成，等待编辑决定呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e14c55942, createdName=lanhai, createdTime=Sun Apr 13 18:08:40 CST 2025, time=2025-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2219820, encodeId=3e6222198204f, content=暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e529420835, createdName=ms2000000634155448, createdTime=Tue Aug 13 08:56:19 CST 2024, time=2024-08-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2156580, encodeId=df8621565804a, content=审稿速度:2.0<br>经验分享：之前投过一次，编辑综合审稿人意见让修改后重投，7月17日投稿，很快送外审，9月4号外审结束（Required Reviews Completed），不知这次编辑怎么看？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ff0b2457930, createdName=StarJay, createdTime=Thu Sep 07 16:41:33 CST 2023, time=2023-09-07, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1243071, encodeId=af3412430e142, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：医学;纳米<br>经验分享：杂志非常效率，1个月内给结果。找了5个审稿人，审稿人意见专业中肯。今年IF10.78，值得投资。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c322575811, createdName=12592582m91暂无昵称, createdTime=Sun Sep 04 09:52:39 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116663, encodeId=7c5d1116663f0, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221462, encodeId=e0a512214620d, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:00 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116664, encodeId=833a11166643f, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-09-04 12592582m91暂无昵称

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：医学;纳米
    经验分享：杂志非常效率，1个月内给结果。找了5个审稿人，审稿人意见专业中肯。今年IF10.78，值得投资。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2264002, encodeId=df7022640023f, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf439560030, createdName=ms8000001925736583, createdTime=Thu May 08 10:49:21 CST 2025, time=2025-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2260232, encodeId=d8c12260232fc, content=投稿命中率:25.0<br>偏重的研究方向：生物学<br>经验分享：投稿了一次，送审很快，审稿完成，等待编辑决定呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e14c55942, createdName=lanhai, createdTime=Sun Apr 13 18:08:40 CST 2025, time=2025-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2219820, encodeId=3e6222198204f, content=暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e529420835, createdName=ms2000000634155448, createdTime=Tue Aug 13 08:56:19 CST 2024, time=2024-08-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2156580, encodeId=df8621565804a, content=审稿速度:2.0<br>经验分享：之前投过一次，编辑综合审稿人意见让修改后重投，7月17日投稿，很快送外审，9月4号外审结束（Required Reviews Completed），不知这次编辑怎么看？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ff0b2457930, createdName=StarJay, createdTime=Thu Sep 07 16:41:33 CST 2023, time=2023-09-07, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1243071, encodeId=af3412430e142, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：医学;纳米<br>经验分享：杂志非常效率，1个月内给结果。找了5个审稿人，审稿人意见专业中肯。今年IF10.78，值得投资。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c322575811, createdName=12592582m91暂无昵称, createdTime=Sun Sep 04 09:52:39 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116663, encodeId=7c5d1116663f0, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221462, encodeId=e0a512214620d, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:00 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116664, encodeId=833a11166643f, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 桑晒麦拉

    RUNINGTITLE是必须的么？

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2264002, encodeId=df7022640023f, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf439560030, createdName=ms8000001925736583, createdTime=Thu May 08 10:49:21 CST 2025, time=2025-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2260232, encodeId=d8c12260232fc, content=投稿命中率:25.0<br>偏重的研究方向：生物学<br>经验分享：投稿了一次，送审很快，审稿完成，等待编辑决定呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e14c55942, createdName=lanhai, createdTime=Sun Apr 13 18:08:40 CST 2025, time=2025-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2219820, encodeId=3e6222198204f, content=暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e529420835, createdName=ms2000000634155448, createdTime=Tue Aug 13 08:56:19 CST 2024, time=2024-08-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2156580, encodeId=df8621565804a, content=审稿速度:2.0<br>经验分享：之前投过一次，编辑综合审稿人意见让修改后重投，7月17日投稿，很快送外审，9月4号外审结束（Required Reviews Completed），不知这次编辑怎么看？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ff0b2457930, createdName=StarJay, createdTime=Thu Sep 07 16:41:33 CST 2023, time=2023-09-07, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1243071, encodeId=af3412430e142, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：医学;纳米<br>经验分享：杂志非常效率，1个月内给结果。找了5个审稿人，审稿人意见专业中肯。今年IF10.78，值得投资。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c322575811, createdName=12592582m91暂无昵称, createdTime=Sun Sep 04 09:52:39 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116663, encodeId=7c5d1116663f0, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221462, encodeId=e0a512214620d, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:00 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116664, encodeId=833a11166643f, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-05-21 peach_adore

    mark

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2264002, encodeId=df7022640023f, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享：很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf439560030, createdName=ms8000001925736583, createdTime=Thu May 08 10:49:21 CST 2025, time=2025-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2260232, encodeId=d8c12260232fc, content=投稿命中率:25.0<br>偏重的研究方向：生物学<br>经验分享：投稿了一次，送审很快，审稿完成，等待编辑决定呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e14c55942, createdName=lanhai, createdTime=Sun Apr 13 18:08:40 CST 2025, time=2025-04-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2219820, encodeId=3e6222198204f, content=暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e529420835, createdName=ms2000000634155448, createdTime=Tue Aug 13 08:56:19 CST 2024, time=2024-08-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2156580, encodeId=df8621565804a, content=审稿速度:2.0<br>经验分享：之前投过一次，编辑综合审稿人意见让修改后重投，7月17日投稿，很快送外审，9月4号外审结束（Required Reviews Completed），不知这次编辑怎么看？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ff0b2457930, createdName=StarJay, createdTime=Thu Sep 07 16:41:33 CST 2023, time=2023-09-07, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1243071, encodeId=af3412430e142, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：医学;纳米<br>经验分享：杂志非常效率，1个月内给结果。找了5个审稿人，审稿人意见专业中肯。今年IF10.78，值得投资。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c322575811, createdName=12592582m91暂无昵称, createdTime=Sun Sep 04 09:52:39 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116663, encodeId=7c5d1116663f0, content=RUNINGTITLE是必须的么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221462, encodeId=e0a512214620d, content=mark, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200806/084a1fc92a044bc49a2f018db2b60b9d/e9eb8f6f5c374213895e9be5cfdc9022.jpg, createdBy=48191511589, createdName=peach_adore, createdTime=Sat May 21 21:29:00 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1116664, encodeId=833a11166643f, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:56 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 乌云背后的幸福线

    RUNNINGTITLE和TITLE的区别？

    1

    展开1条回复
共17条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分